Xiaoyi Hu
Xiaoyi Hu
1
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3
Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
4
Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1,2,3,4,†,
Mingyang Bao
Mingyang Bao
5
State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, China
5,†,
Jiacheng Huang
Jiacheng Huang
1
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3
Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
4
Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1,2,3,4,
Lin Zhou
Lin Zhou
2
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3
Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
4
Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2,3,4,*,
Shusen Zheng
Shusen Zheng
1
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3
Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
4
Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
1,2,3,4,*
1
Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
2
National Health and Family Planning Commission of China Key Laboratory of Combined Multi-Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
3
Key Laboratory of the Diagnosis and Treatment of Organ Transplantation, Research Unit of Collaborative Diagnosis and Treatment for Hepatobiliary and Pancreatic Cancer, Chinese Academy of Medical Sciences, Hangzhou, China
4
Key Laboratory of Organ Transplantation, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China
5
State Key Laboratory of Genetic Engineering, School of Life Sciences, Institute of Biostatistics, Fudan University, Shanghai, China
Approved by: Frontiers Editorial Office, Frontiers Media SA, Switzerland
✉*Correspondence: Lin Zhou, zhoulin99@zju.edu.cn; Shusen Zheng, shusenzheng@zju.edu.cn
†These authors have contributed equally to this work
This article was submitted to Molecular and Cellular Oncology, a section of the journal Frontiers in Oncology
Received 2020 Oct 15; Accepted 2020 Oct 16; Collection date 2020.
Keywords: prognosis, biomarker, GEO, hepatocellular carcinoma (HCC), diagnosis
Copyright © 2020 Hu, Bao, Huang, Zhou and Zheng
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
